Client Challenge
Thrilled to share our latest review on my favourite platelet population, the #procoagulant platelet, and its role across cardiovascular diseases and thrombinflammation, out today in @natrevcardiol.nature.com π«
www.nature.com/articles/s41...
Find the full version here: rdcu.be/eY5ft
14.01.2026 21:03 β π 0 π 0 π¬ 0 π 0
Today, we see the fruit of 5+ years of teamwork. We have built a map of the neutrophil compartment (mostly in mice - but also humans). It provides a biological structure that focuses on a single immune cell lineage to discover the many ways in which neutrophils "interpret" physiology.
03.12.2025 18:57 β π 25 π 11 π¬ 3 π 1
@youngdzhk.bsky.social @dzhk.de @ekfstiftung.bsky.social
01.05.2025 18:44 β π 2 π 1 π¬ 1 π 0
Thieme E-Journals - Thrombosis and Haemostasis / Abstract
Thieme E-Books & E-Journals
Plus there's more: @thjournal.bsky.social asked us to write a comprehensive update on #immunothrombosis and #thromboinflammation - another fun collab with Christoph Gold and Konstantin Stark @lmumuenchen.bsky.social
www.thieme-connect.com/products/ejo...
01.05.2025 18:44 β π 1 π 0 π¬ 1 π 0
Read more above - kudos and congratulations to lead author Kami Pekayvaz and senior authors @immunothrombosis.bsky.social and Konstantin Stark!
01.05.2025 18:35 β π 1 π 0 π¬ 0 π 0
Happy to share the most recent work from our lab, now out in #Immunity @cp-immunity.bsky.social - a single-cell atlas of mammalian thrombosis that uncovers unexpected traits of #neutrophil-#monocyte interplay in a process termed "immunothrombolysis". Read more below!
01.05.2025 18:35 β π 5 π 1 π¬ 1 π 0
All in all, a great week for our lab filled with translationally relevant new findings - stay tuned for more! 4/4
@immunothrombosis.bsky.social @ash.hematology.org @ekfstiftung.bsky.social @dfg.de @dzhk.de @youngdzhk.bsky.social
05.04.2025 05:51 β π 2 π 0 π¬ 0 π 0
Out on the same day, an exciting study from Thomas Thiele's lab at Uni Greifswald describes an intricate mechanism of histone/anti-histone IgG-mediated platelet activation in anti-PF4 negative thrombosis and thrombocytopenia syndrome in@bloodadvances.bsky.social (ashpublications.org/bloodadvance...)
05.04.2025 05:51 β π 1 π 0 π¬ 1 π 0
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma
Key PointsCD86 is a promising immunotherapeutic target in cHL, and the CD86βCTLA-4 axis orchestrates an immunosuppressive cHL tumor microenvironment.CD86-t
In the same issue, @adriangottsch.bsky.social from the Kobold lab at @lmumuenchen.bsky.social LMU Klinikum MΓΌnchen describes a revolutionary and exciting strategy approach to classic Hodgkin lymphoma using single-cell omics and a CD86-based CAR T cell approach.
ashpublications.org/blood/articl...
05.04.2025 05:51 β π 1 π 0 π¬ 1 π 0
Excited to share the most recent work from our lab and results from two exciting cooperations:
In this week's issue of @bloodjournal.bsky.social (ashpublications.org/blood/issue), Afra Anjum presents her cover story on how aging platelets gain inflammatory functions in the circulation. 1/4
05.04.2025 05:51 β π 9 π 4 π¬ 1 π 0
1/x Online now: Our work on platelet aging and inflammation in @bloodjournal.bsky.social led by superstar PhD student Afra Anjum: ashpublications.org/blood/articl...
23.01.2025 10:38 β π 31 π 9 π¬ 2 π 1
IZTECH-Chemistry, I like to be Polymath(learning different subjects), Polygot(interested in the learning different languages) comments and opinions are my own RTβ is not endorsement (he/him)
Interventional cardiologist @KlinikumErding, cardiac implantable devices, hypertension. #cardiosky #medsky Cycling π΄and sailing β΅οΈ
All things art and internal medicine (primary interest in cardiokidneymetabolic syndrome (Diabetes, CKD, Electrolyte Disorders, Heart Failure, Lipids etc)). Based in Vienna.
Das Wissensportal für #Kardiologie & #Herzgesundheit wird von der @dgk-org.bsky.social⬠und dem BNK herausgegeben.
Impressum: Herzmedizin.de/i
Datenschutz: Herzmedizin.de/d
Netiquette: Herzmedizin.de/n
#Herzmedizinde #DGK #Cardiology #CardioSky #MedSky
Scripps Research is one of the world's largest, private, non-profit biomedical research organizations. We are Science Changing Life.
The cluster of excellence CECAD @UniCologne performs research in #Aging & aging-associated diseases | Tweets in English & German | Imprint: http://bit.ly/cecad-notice
Scientist working on kidney diseases. Focus on ciliopathies, CKD, and podocytes - private account.
NCI NRSA Postdoctoral Fellow at @CCLRI and @ClevelandClinic | Lathia Laboratory | Cameron laboratory | @CWRUSOM Alum | Husband |Twin Girl dad | Tweets are my own
#thrombosis #plateletimmunecellcrosstalk #Braintumors #sexdifferencesincancer
Postdoc @ipekresearch | Passionate about angiogenesis, atherosclerosis and cell metabolism
Research Fellow @ MRC WIMM. Permanent resident of tissue culture hood 82. Organoids, bone marrow and haematopoeisis by day. Heavy metal, climbing, bookworm also by day letβs be honest Iβm too old to do anything in the evenings any more.
Nephrologist/Professor. Associate Editor Clinical Kidney Journal. Dogs, cooking, classical music. views own #Medsky #Nephsky
https://www.unimedizin-mainz.de/medizinische-mikrobiologie-und-hygiene/
#DGfI #DGHM #EFIS #IUIS / π¦βοΈπ¦ π¬π§«ππ§/ #immunometabolism / #host-pathogen interaction / πͺπΊ / #UM #JGU: excellence in basic research and health care / own views only
The Ludwig-Maximilians-UniversitΓ€t in Munich founded the Center for Advanced Studies in 2008. Since then, fellows from all over the world joined CAS.
The official account of Nature Reviews Cardiology, a monthly journal publishing high-quality Reviews, news and opinion articles covering all aspects of basic and translational cardiovascular research and clinical cardiology: https://www.nature.com/nrcardio
Official American College of Cardiology account. Join us to transform cardiovascular care & improve heart health for all π«π©Ίπ| ACC.org.
Nature Portfolioβs high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
